[HTML][HTML] Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens
A Martinetti, R Miceli, E Sottotetti, M Di Bartolomeo… - Cancers, 2014 - mdpi.com
The need to identify biomarkers for bevacizumab-based treatment in advanced colorectal
cancer is imperative. The aim of this study was to investigate the prognostic role of …
cancer is imperative. The aim of this study was to investigate the prognostic role of …
[HTML][HTML] Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens
A Martinetti, R Miceli, E Sottotetti, M Di Bartolomeo… - Cancers, 2014 - ncbi.nlm.nih.gov
The need to identify biomarkers for bevacizumab-based treatment in advanced colorectal
cancer is imperative. The aim of this study was to investigate the prognostic role of …
cancer is imperative. The aim of this study was to investigate the prognostic role of …
Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens
A Martinetti, R Miceli, E Sottotetti, M Di Bartolomeo… - CANCERS, 2014 - air.unimi.it
The need to identify biomarkers for bevacizumab-based treatment in advanced colorectal
cancer is imperative. The aim of this study was to investigate the prognostic role of …
cancer is imperative. The aim of this study was to investigate the prognostic role of …
[PDF][PDF] Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens
A Martinetti, R Miceli, E Sottotetti, M Di Bartolomeo… - core.ac.uk
The need to identify biomarkers for bevacizumab-based treatment in advanced colorectal
cancer is imperative. The aim of this study was to investigate the prognostic role of …
cancer is imperative. The aim of this study was to investigate the prognostic role of …
Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens.
A Martinetti, R Miceli, E Sottotetti, M Di Bartolomeo… - …, 2014 - search.ebscohost.com
The need to identify biomarkers for bevacizumab-based treatment in advanced colorectal
cancer is imperative. The aim of this study was to investigate the prognostic role of …
cancer is imperative. The aim of this study was to investigate the prognostic role of …
[引用][C] Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens
A Martinetti, R Miceli, E Sottotetti, M Di Bartolomeo… - Cancers, 2014 - cir.nii.ac.jp
Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to
Three Bevacizumab-Based Regimens | CiNii Research CiNii 国立情報学研究所 学術情報 …
Three Bevacizumab-Based Regimens | CiNii Research CiNii 国立情報学研究所 学術情報 …
[PDF][PDF] Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens
A Martinetti, R Miceli, E Sottotetti, M Di Bartolomeo… - 2014 - Citeseer
The need to identify biomarkers for bevacizumab-based treatment in advanced colorectal
cancer is imperative. The aim of this study was to investigate the prognostic role of …
cancer is imperative. The aim of this study was to investigate the prognostic role of …
[PDF][PDF] Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens
A Martinetti, R Miceli, E Sottotetti, M Di Bartolomeo… - pdfs.semanticscholar.org
The need to identify biomarkers for bevacizumab-based treatment in advanced colorectal
cancer is imperative. The aim of this study was to investigate the prognostic role of …
cancer is imperative. The aim of this study was to investigate the prognostic role of …
circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens
A Martinetti, R Miceli, E Sottotetti… - The Journal of …, 2014 - scimatic.org
The need to identify biomarkers for bevacizumab-based treatment in advanced colorectal
cancer is imperative. The aim of this study was to investigate the prognostic role of …
cancer is imperative. The aim of this study was to investigate the prognostic role of …
[PDF][PDF] Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens
A Martinetti, R Miceli, E Sottotetti, M Di Bartolomeo… - cyberleninka.org
The need to identify biomarkers for bevacizumab-based treatment in advanced colorectal
cancer is imperative. The aim of this study was to investigate the prognostic role of …
cancer is imperative. The aim of this study was to investigate the prognostic role of …